CEOWORLD magazine

5th Avenue, New York, NY 10001, United States
Phone: +1 3479835101
Email: info@ceoworld.biz

Anna Siampani

Anna Siampani

Anna Siampani, Lifestyle Editorial Director at the CEOWORLD magazine, working with reporters covering the luxury travel, high-end fashion, hospitality, and lifestyle industries. As lifestyle editorial director, Anna oversees CEOWORLD magazine's daily digital editorial operations, editing and writing features, essays, news, and other content, in addition to editing the magazine's cover stories, astrology pages, and more. You can reach Anna by mail at anna@ceoworld.biz
CEO Explainers

Michael Rhodes Becomes the new CEO of Discover Financial Services

Discover Financial Services' board has announced the appointment of Michael G. Rhodes as the new Chief Executive Officer and a board member, effective from March 6, as per the company's filing on Monday. John Owen, the interim CEO, will continue to serve as a director of the company and the...
CEO Explainers

Arena Group Dismisses its CEO

The Arena Group, a digital publisher responsible for renowned brands like Sports Illustrated and The Street, dismissed its CEO on Monday, part of a broader restructuring within the top leadership. Ross Levinsohn held the position of CEO for three years, and the decision followed a troubling incident where Sports Illustrated...
CEO Explainers

Allianz Names CEO for Central Europe

Allianz SE has announced the appointment of Nina Klingspor, the current CEO of Allianz Private Krankenversicherungs-AG (APKV), Allianz's private health insurance business in Germany, as the upcoming Chief Executive Officer of Central Europe for Allianz Group.  This appointment is pending approval by the relevant corporate bodies. Klingspor will succeed Petros...
Healthcare EKF Diagnostics
CEO Explainers

Rhythm Pharmaceuticals CFO Sells Shares

During a recent transaction on December 6, 2023, Hunter Smith, the Chief Financial Officer of Rhythm Pharmaceuticals Inc., executed a substantial sale of company shares. Smith's disposal of 27,026 shares of Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) has garnered attention from both investors and market analysts. Rhythm Pharmaceuticals Inc. is a...
1 288 289 290 291 292 438
Page 290 of 438